Early Detection of Cancer and Infection Can Change the Ballgame
Dr Arvinder Singh, CEO and CMD of Arth Diagnostics shared his experiences and research in the National Alliance Meet organised by Japanese company 'Horiba' at Hyderabad.
Dr Arvinder Singh, CEO and CMD of Arth Diagnostics shared his experiences and research in the National Alliance Meet organised by Japanese company ‘Horiba’ at Hyderabad. He explained that how new technology by the machine ‘Yumizen’ can change the diagnostic landscape in a very cost effective and quality sensitive manner.
The machine detects the abnormality at very early stage by latest amalgamation of technologies like cytochemistry, flow cytometry and impedance. The machine provides six part analysis of the blood samples and give special alarms for cancer and infection cells.
Early diagnosis is the key for proper treatment and management of the patients. There is a common saying – “kill the monster while it’s little”. So is the case with the diseases, because at initial stages the diseases are curable with little costs and morbidity. The machine was evaluated before launch in India by Dr Singh and Dr Dharav at Udaipur and Mumbai Centre respectively.
The National conference was attended by more than 150 persons from technical team and distribution chain. Dr Jai Hakhu, chairman of Horiba International Corporation and Dr. Rajeev Gautam the Managing Director Horiba expressed his views and facilitated the alliances.
The new technology was well appreciated and was being warmly welcomed by national associates. In the record time of 45 minutes more than 80 machines were purchased to be installed across India.